Suprainguinal Fascia Iliaca Block in Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 3, 2024

Conditions
AnalgesiaAnesthesia, Local
Interventions
OTHER

control group; Patients who received physiological saline

All patients will be given 1 gram of paracetamol intravenously + 20 milligrams of tenoxicam + 8 milligrams of decort intravenously. Paracetamol 3x1 gram + tenoxicam 2x20 milligrams will continue to be administered. Patients in the control group will be given 40 milliliters of physiological saline during the suprainguinal fascia iliaca block.

OTHER

suprainguinal fascia block; Patients receiving local anesthetic

All patients will be given 1 gram of paracetamol intravenously + 20 milligrams of tenoxicam + 8 milligrams of decort intravenously. Paracetamol 3x1 gram + tenoxicam 2x20 milligrams will continue to be administered. Patients in the sfıb group will be given 40 milliliters of 0.25 % bupivacaine during the suprainguinal fascia iliaca block.

Trial Locations (1)

42020

Konya City Hospital, Konya

All Listed Sponsors
lead

Konya City Hospital

OTHER

NCT06386575 - Suprainguinal Fascia Iliaca Block in Knee Arthroplasty | Biotech Hunter | Biotech Hunter